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PATENT COOPERATION TREATY - IMPLEMENTATION V. U.S. LAW
RICHARD LAZARUS*

Let us assume a client has just walked into your office and explained that they
are being sued for infringement of a United States patent. The plaintiff is asking for
many millions of dollars and the client desperately needs your help. Of course, the
first thing to be done is to determine if there is actual infringement of the claims of
this patent. You realize that the other side has done a pretty good job and that there
appears to be infringement. You do not want to have to argue that there is no
infringement.
So now what? The client is faced with substantial damages if you cannot help
him. The next thing that comes to most attorneys' minds is the question of whether
the patent is valid. Is there any prior art out there that could invalidate this patent?
This is one avenue to pursue. Also, you should ask whether there is anything in the
file that could invalidate or render the patent unenforceable. Maybe there was an
abandonment of the application during the process that would render this invalid or
unenforceable. The face of the patent shows there is benefit under the Patent
Cooperation Treaty ("PCT") of an earlier PCT application. In order to determine if
there are any validity or enforceability issues arising under the PCT or corresponding
U.S. law you must order and review the PCT files.
What PCT files are there? There is a receiving office file, a searching authority
file and an international bureau file. If a demand for examination has been filed
there will also be an examination file. An international application is filed with a
receiving office. The receiving office processes the original papers on which a filing
date is granted.
The receiving office sends those original papers on to the
International Bureau. The International Bureau keeps the original papers for
themselves and makes a copy to send to the International Searching Authority.
Then, the examiner at the searching authority provides a search. The International
Searching Authority has a file and, as already explained, the International Bureau
and Receiving office have files. The International Bureau will get a copy of the
search report and publish it with the application.
If the applicant wishes
examination and files a demand for an international preliminary examination there
will, of course, be an examination file.
At the end of this article are three examples of the first page of a U.S. patent.
Each first page demonstrates reliance on a PCT filing. These examples demonstrate
how to quickly determine if the U.S. patent, of which your client is accused of
infringing, is based on a prior PCT application. The first example shows a national
stage filing. The front page of the patent shows that there was a prior PCT
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application and gives the Section 371(c) U.S. national stage entry date.1 Section 371
is a portion of Title 35, of the Patent Statute, that dictates how one enters the
national stage after a PCT filing. 2 This means that the U.S. Patent and Trademark
Office takes the International Bureau's copy of the international application with the
fee and other national stage papers provided by applicant, and forwards them to the
examiner in the U.S. Patent Office for examination.
The second example occurs when applicants do not enter the national stage, but
choose, instead, to file a continuation. This is an example of an applicant who has
chosen to use 111(a) route provided by the statute. 111(a) is the only other way,
besides Section 371, to get an application on file in the patent office. 3 Under 111(a),
one provides a copy of the disclosure and asks for a filing date. In this second
situation, there is a claim for benefit of the prior PCT application that is apparent.
The third example demonstrates the situation when an application is from a series of
previous applications, one of which was either a national stage or a continuation of a
PCT.
After observing that the patent relies on a PCT filing and obtaining the
receiving office, international searching authority, the International Bureau, and in
examination cases the international preliminary examining authority files, now
what? There are many issues to look for in the PCT files. Some of these can be very
helpful to one's client to perhaps avoid the very expensive costs of being an infringer.
The following five issues are discussed: (1) searching for new matter; (2) searching for
errors in claimed inventorship; (3) examining an international filing date; (4)
checking for withdrawal of an international application; and (5) examining estoppel
arguments in international applications.

A. New Matter
The first issue is new matter. As many are aware, U.S. law says that new
matter may not be introduced into a patent application. 4 The Patent Cooperation
Treaty also forbids this. Can international application files have new matter?
Speaking from my experience and the number of files that I have seen, the answer,
surprisingly, is - yes, they can.
5
How does the new matter get in? Article 19 of the Patent Cooperation Treaty
explains that when the applicant gets the search report, they have a limited time to
amend the claims. That is, the search is completed and the applicant is given two
months to look at that search report and make a decision as to whether there is any
prior art that would cause their claims to be rendered unpatentable. If there is such
prior art, the applicant has an opportunity to amend the claims in accordance with
PCT Article 19. The applicant then sends the claim amendment to the International
Bureau, which publishes those claims. There is an advantage to an applicant to have

U.S.C. § 371 (2000).
Id.
3 Id. at § 111(a).
4 Id. at § 132 (forbidding the introduction of new matter into patent applications).
, Patent Cooperation Treaty art. 19, June 19, 1970, 28 U.S.T. 7645, 116 U.N.T.S. 231,
available at http://www.wipo.int/pct/en/texts/articles/atoc.htm [hereinafter PCT].
1 35
2
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his claims published. For those published claims that survive to the patent, one can
get protection all the way back to the publication of those claims. This is called
provisional patent protection. After the applicant gets the search report, the
applicant sends those Article 19 Amendments to the International Bureau so that
they will be published with the international application.
No one at the
International Bureau looks at the amendments to check for new matter. There are
no examiners at the International Bureau; there is no one qualified to look for new
matter. If any new matter is included, it simply is published and included with the
application. One should compare the Article 19 amendments with the original
disclosure to discover if such amendment has introduced new matter.
Article 34 Amendments 6 are a little different. Those amendments come during
the examination phase. They go to an examiner at the international preliminary
examining authority. An examiner will examine such amendments for new matter.
If the examiner finds there is new matter, he will refuse the amendments. For
example, if the European Patent Office ("EPO") is the examining authority, an
examiner in the EPO will examine the Article 34 amendments. The EPO has a
slightly different new matter standard than the United States. So, you will want to
look at these amendments and compare them with the original disclosures in the
application to determine if new matter has been introduced.
Another way that new matter can get into these files is called ex officio changes.
The guidelines and administrative instructions authorize various international
authorities to make changes to the application. They are supposed to be harmless
changes. These are changes made, in effect, by clerical staff, some of whom are welltrained, although some are not. Some of the clerical staff go beyond and make
changes that perhaps should not be made. Some of the changes could be determined
to be new matter.
Another potential source of new matter is through a request for rectification.
When the international application is filed, the receiving office quickly notifies the
applicant of formal errors, e.g., that some of the margins are off, that there are some
lines in the drawings, or other similar defects indicating that the application is not
sufficient for publication. The office gives the applicant a month to correct. The
applicant then provides changes to the application. Perhaps the applicant sees some
changes they would like to make on their own. There may have been some
misspellings in the disclosure. Maybe the office felt the applicant left out some kind
of chemical symbol, so the receiving office just puts it in. When those papers come in,
the receiving office stamps those papers with two stamps. The stamp at the top
includes the date that the office received the papers. The other stamp is at the
bottom and indicates the type of change being approved. Or, if they choose to not
enter the paper, there is no stamp at the bottom. If the office does enter the paper,
the office can indicate that it is an amendment, or a substitute sheet. The stamp
"substitute sheet" on the bottom means that the clerical person examined the
amendment and certifies that the only changes are formalities; there are no
substantive changes. This substitute sheet stamp is applied so that people who later
see the sheet will not have to review it for possible substantive changes. In my view,

6 PCT, supra note 5, art. 34.
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it is a good idea to look at the sheet to see if there are any substantive changes or if
any new matter has crept into the application. For example, the applicant may have
changed the range of an amount of cadmium or other element used in a
pharmaceutical drug application. This change could be mere movement of a decimal
point and could be introduction of new matter into the application.
Another way to review these files for new matter is by comparison of the
publication with the original disclosure. The International Bureau is the one that
puts together the eighteen month publication. The Bureau is supposed to do it from
the original disclosure and make sure nothing is added. However, in each application
there are potentially several submissions from various groups (receiving office,
applicant, and International Bureau), and each of these presents a possibility for
adding new matter. This is why the International Bureau's publication can end up
containing new matter.
Additionally, new matter can be introduced when an application enters the
national stage. If the international application was published in, Japanese, German,
or another language other than English, then when the applicant comes to enter the
national stage he must provide an English translation. Did that translator provide
an accurate translation? Or again, were some of the terms used perhaps a little
expansively so as to add new matter to that disclosure?
And the last potential source of new matter is continuation. I always scratch my
head a little bit, maybe too much, asking myself, why people would file a
continuation instead of entering the national stage. To initiate entry into the
national stage all one really needs to do is pay the fee and identify the international
(PCT) application. If it is published in English, a copy of the disclosure is not needed.
However, some people come in with a new copy of the disclosure. Instead of
proceeding under Section 371 of the statute, 7 they proceed under Section 111 of the
statute. 8 They provide the U.S. Patent and Trademark office with a new disclosure.
So, in the case of a 111(a) continuation application, one should always ask, "what is
in that new disclosure that is not in the PCT case?" It is prudent to make sure you
look at an original copy of the PCT application papers that were filed, and check
those against the continuation papers for possible new matter.

B. Inventorship
The second issue is inventorship. We all know that the law of the U.S. requires
the applicant for U.S. patents to be the inventor, or if there are multiple inventors, a
joint inventor. 9 Here, one should look outside of Chapter 11 at Section 373 of the
United States Code, which is something that people do not ever seem to do. 10 This
section states that if an international application was filed by someone not qualified,
e.g., not an inventor, under Chapter 11 of the Statute, it can not be accepted for the
7

35 U.S.C. § 371 (2000).
§ 111.

8 Id. at
9

Id. See 37 C.F.R. § 1.41 (2006) ("A patent is applied for in the name or names of the actual

inventor or inventors."), and 37 C.F.R. § 1.45 (2006) (requiring joint inventors to apply for a patent
jointly and that each inventor make the required oath or declaration).

10 35 U.S.C. § 373.
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U.S. national stage. Thus, the U.S. Patent Office cannot accept an application for the
national stage under Section 371 if the PCT was filed by someone not qualified under
Chapter 11 of the United States Code. Furthermore, it states that under these
circumstances (the wrong inventor in the PCT) one cannot file a continuation of that
PCT application. I can not count the number of instances I have seen in which the
inventorship has changed in an international application after the filing date. It is
not an unusual occurrence. What is a proper change? Is it the type of change that
runs afoul of Section 373 of the Statute? Unfortunately, there is not any case law
that I am aware of that addresses this issue. You should examine all of the facts to
see if the PCT application was filed by someone other than the correct inventor and,
if so, whether there is compliance with all of the necessary statutory requirements,
including Section 373.

C. FilingDate
The next issue is the filing date. I want to take you back just a little bit to give
you some of my experience. In the 1970s, if there was an alleged infringement of a
U.S. patent, the attorney would first order the patented file. The reason he would
order the U.S. file was to review the U.S. filing date requirements. Back then,
beyond the disclosure that one needs now, one also needed a filing fee and an oath or
declaration by the inventor. Attorneys were surprisingly good at finding defects in
those requirements. When defects were uncovered, there went the filing date; and
there went the patent. The attorneys could also find troubling things that happened
in the U.S. Patent Office, such as situations in which an applicant paid the fee using
his deposit account and there was not enough money in that account. Or, on
occasion, the check that the applicant used to pay the fee bounced. U.S. law changed,
so we do not have to worry about those types of filing date requirements anymore.
Unfortunately, Article 11,11 which is the filing date provision under the treaty,
developed along some of the same lines as the old U.S. filing date requirements.
There are a lot of requirements in Article 11, and it has never been changed. Some
things in it are maybe a little bit onerous that we could do away with, but we have
not. However, this is the law. When one files an international application in a
receiving office, one must have it in the prescribed language. It has to be a language
that is acceptable to that receiving office. If one files in the wrong language, one does
not get that filing date. If one misses that filing date, one might go beyond the Paris
Convention year and could lose his or her priority date. A lot of things could happen.
Furthermore, the applicant must be qualified. An applicant who is a resident or
national qualifies to file. These are all Article 11 provisions and one should examine
the receiving office file to be sure the Article 11 requirements were met. That is, it is
wise to order the files and look especially at the receiving office file to determine for
yourself if the PCT application was entitled to the international filing date that it
was given.

I

PCT, supra note 5, art 11.
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D. Withdrawal
The next issue is withdrawal. What is a withdrawal? There are basically three
types of withdrawals. An applicant can withdraw the priority claim asserted in the
international application, he can withdraw the demand for examination, or he can
withdraw the whole application. But, why would anybody want to give up any of
these rights in an international application?
First, maybe the applicant did not want to have the case published, or he wanted
to delay publication. Or, maybe he wanted to keep the invention as a trade secret.
Then, the applicant withdraws the priority claim before technical preparation of that
publication is complete, and the Bureau does not publish it. The priority date is reset
if there is another priority claim. Or, if there is none, then the international filing
date is used to calculate the periods running from the priority date. This type of
withdrawal can give an applicant more time to make economic or business decisions.
In such instances they are losing a priority claim. Sometimes, however, applicants
will later reassert a priority claim in the national stage. You should review the
application papers for such change.
You should look at the international preliminary examination file. Unusual
things can be uncovered in such files. For example, why would an applicant ever
withdraw the demand for examination? Consider the situation where an applicant
gets a written opinion or a report that says some of their claims are unpatentable. If
he or she gets a written opinion to that effect, the applicant considers whether
amendment is possible to avoid the rejection. If the applicant can not amend, he is
stuck. And perhaps he already has received a patent in one country. Maybe other
countries will give the applicant patents too, but not if they see this report. So, the
applicant enters the national stage and then withdraws the demand. What that
means is that nothing from the examination file gets sent to any of the designated
countries. It is locked up, because after publication one can see all different parts of
the international application, but not the international preliminary examination
material. That is the only thing that is kept confidential unless the applicant
permits the examination file to be copied or reviewed. That is one reason why an
applicant might want to withdraw the demand.
Why would an applicant want to withdraw the international application? Why
would there ever be something like that in the file? As someone who has looked at a
lot of these applications, there are many different things that could have happened.
A secretary may be instructed by the attorney to withdraw an application, because
the client is not paying his bills. Alternatively, the applicant may say he wants to
abandon the application. Clerical mistakes can occur. A secretary could type up a
letter of withdrawal for international application number five, when the attorney
requested withdrawal of application number six. The attorney signs, and they send
it in. Then where are they? The attorney writes a quick letter stating, "We withdrew
number five. We intended to withdraw number six." The international authority
would perhaps respond, "Okay. You're back in business. We're going to rescind that."
Under what authority can the international authority do this? I have always
wondered, how this happens, but it has happened. Is that going to be of any value to
you when you are looking at the patent in this case? Perhaps. I mention this
because these withdrawals and the effects of these withdrawals are something you
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should look for if you want to make a proper evaluation of the validity and
enforceability of the patent in question.
The Statute says if an international application is withdrawn before an
applicant has entered the national stage, or before he has filed a continuation, the
international application is considered not to have been filed. 12 As many people
know, if a U.S. application goes abandoned, it was pending from the time it was filed
until the time it went abandoned. The penalty for withdrawal is much more severe.
A withdrawn application is considered as though it had never been filed. So,
withdrawals are very important. One does not know how a judge would look at a
withdrawn PCT application followed by a subsequent U.S. application having benefit
of the PCT application, but it is my belief that there have been many of these
situations.

E. EstoppelArguments
Finally, there are estoppel arguments. Throughout the prosecution of the
international application one will find statements by applicants, attorneys, and the
international authorities. Explanations may accompany the applicants request for
rectification of some apparently minor change.
One would be amazed at the
comments that applicants and attorneys provide with those changes. Applicants
often do not need to put in any comments. However, they often do provide comments,
and the question arises: Could such comments be estoppel arguments? Absolutely.
Look especially at the Article 19 13 and Article 34 14 Amendments.
Article 34
Amendments are submitted to the examiner to overcome written opinions rejections.
The entire Article 34 amendment does not get forwarded to the national offices. One
will find the Article 34 claims in the national stage files. One will not find the
comments that were provided to the international preliminary examining authority
with the Article 34 Amendments, because they are not forwarded to the national
offices for the national stage files. The only way one can see the arguments is if one
gets a copy from the applicant or the International Preliminary Examining
Authority.
In conclusion, these are five possible issues to explore when assisting a party
accused of infringement. These five issues demonstrate the importance of examining
the PCT files for possible validity and enforceability issues.

12

35 U.S.C. § 366.

13 PCT, supra note 5, art. 19.
'1 PCT, supra note 5, art. 34.
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EXAMPLE 2: U.S. PATENT -
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EXAMPLE 3: U.S. PATENT DOMESTIC (35 U.S.C. § 120)
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